HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
about
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansStructural Neuroimaging Genetics Interactions in Alzheimer's DiseaseCurrent advances in systems and integrative biologyA loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han ChineseRole of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for TreatmentEffect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults.Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease.Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic ReviewThe etiological effect of a new low-frequency variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study
P2860
Q26801647-788925B2-20F3-426E-80F6-03CB3F0C6B09Q28601824-ED5784C8-C925-4180-ACB4-93A65D4FB625Q34417712-A008F50A-CB8E-43EB-929D-E6123CD8F356Q36064459-4FEF2E9C-9059-47EE-93E7-6DFFFF521068Q36764094-1015E774-4AD8-4FBC-9660-EACC6861B88DQ37046346-A87D98D1-761C-4F44-BFC4-9DF964B33358Q37225662-01DE7F68-0D0D-4E4D-B2CF-73CCF0E06507Q37474724-AC29B30B-11C5-4FD4-8DE9-270694F971BCQ37474730-86BD353B-4477-4104-88D4-E8474BBCCC84Q37650830-7AB48994-9083-468C-981D-006D1EE6E9AAQ42653687-FCA8C09A-8538-4128-BE27-8C4ED2B9F816Q47642952-646ECB61-DF84-4230-B2DD-C53802C14960Q48013134-5DD20170-EACD-4415-A749-9232E80E0EA9Q48361868-E6243ABF-F83F-4BEB-AABA-24E79011E54CQ50532477-7E15B046-7457-4A15-BFE7-813C5C62D522Q58549216-E268C4EF-CA58-4FD8-935C-504B088EFD15Q58735427-4CF39B93-FD04-41AB-B738-812C096170F9
P2860
HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@ast
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@en
type
label
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@ast
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@en
prefLabel
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@ast
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@en
P2093
P2860
P356
P1433
P1476
HMGCR is a genetic modifier fo ...... ease in a three cohorts study.
@en
P2093
L De Beaumont
R C Petersen
P2860
P2888
P304
P356
10.1038/MP.2014.81
P407
P577
2014-07-15T00:00:00Z